FDA Drug Application (021222) for SPECTRACEF by VANSEN PHARMA

Back to FDA Applications sponsored by VANSEN PHARMA

Application Number021222
Product Number001
FormTABLET;ORAL
Dosage200MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSPECTRACEF
Active IngredientCEFDITOREN PIVOXIL



Back to FDA Applications sponsored by VANSEN PHARMA